Schedule 13D ownership disclosure

RECURSION PHARMACEUTICALS INC CL A

Security class unavailable · CUSIP: 75629V104

Event date: 2022-10-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
11,291,937
Percent of class
6.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-22-010981
Form type
SC 13D/A
Filer
Mubadala Investment Co PJSC
CIK
CIK 1704268
Filed
Oct 31, 2022
Reporting period
Oct 27, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub